Barely two days after Merck’s Ervebo was granted an EU marketing authorization by the European Commission, the World Health Organization announced that it has prequalified the Ebola vaccine, paving the way for rapid roll-out of the licensed product in African countries at risk from Ebola outbreaks.
The decision, which followed what the WHO said was “the fastest vaccine prequalification process" it had ever conducted, will help to speed up local